Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-24 @ 9:11 PM
NCT ID:
NCT02822404
Eligibility Criteria:
Inclusion Criteria:
* Children of 0 to18 years treated with cisplatin and / or ifosfamide in the hematology-oncology unit of Toulouse University Hospital of children regardless to the pathology they have been treated for
* Children with more than 4kg
* Written informed consent given by both parents or legal representative
* Patient covered by a social security agreement
Exclusion Criteria:
* Impossibility to monitor and follow up the patient until the foreseeable end of the treatment (geographic reasons, etc.)
* Contraindication to EDTA clearance performing
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
18 Years
Study:
NCT02822404
Study Brief:
Protocol Section:
NCT02822404